Cargando…
A novel strategy for identifying biomarker in serum of patient with COVID-19 using immune complex
Autores principales: | Duan, Fugang, Wang, Yifan, Chen, Taoyu, Zhu, Zhu, Yu, Meng, Dai, Hui, Zheng, Shangen, Lu, Yinying, Li, Tingting, Qiu, Xiaoyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882717/ https://www.ncbi.nlm.nih.gov/pubmed/35228518 http://dx.doi.org/10.1038/s41392-022-00909-z |
Ejemplares similares
-
Analysis of TCR Repertoire by High-Throughput Sequencing Indicates the Feature of T Cell Immune Response after SARS-CoV-2 Infection
por: Wang, Yifan, et al.
Publicado: (2021) -
A new strategy: identification of specific antibodies for neutralizing epitope on SARS-CoV-2 S protein by LC-MS/MS combined with immune repertoire
por: Yu, Meng, et al.
Publicado: (2022) -
Novel Strategy for Organic Cocrystals of n-Type
and p-Type Organic Semiconductors with Advanced Optoelectronic
Properties
por: Zou, Taoyu, et al.
Publicado: (2020) -
Serum IgG N-glycans act as novel serum biomarkers of ankylosing spondylitis
por: Wang, Jingrong, et al.
Publicado: (2019) -
Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment
por: Jiang, Tao, et al.
Publicado: (2020)